
Doximity climbs 55% on AI optimism despite earnings miss
Doximity's stock jumped roughly 55% after its fiscal Q1 miss, as CEO Jeff Tangney highlighted a heavy AI investment plan and a 'once-in-a-generation' AI opportunity in medicine. The company’s Ask AI model reportedly outpaced rivals like Anthropic’s Fable 5 in a Stanford-Harvard study, and scribe note usage surged 10x year over year. The quarter showed adjusted earnings of 29 cents on $156.6 million revenue (vs 30 cents and $151.8 million expected), while Q2 revenue guidance was $170–$171 million, underscoring investor optimism about AI-driven growth.


